Related Experiment Video
Updated: Mar 20, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors
Caroline Mohrmann1, Jane Armer2, Robert J Hayashi1
11 Washington University School of Medicine, Saint Louis, MO, USA.
Abstract:
Children treated for cancer are exposed to a variety of chemotherapeutic agents with known toxicity to the peripheral nervous system. The side effect of peripheral neuropathy can cause changes in sensation, function, and even cause pain. Although peripheral neuropathy is recognized by pediatric oncology nurses as an important and significant side effect, measuring neuropathy can be quite complex for clinical care and research efforts. With more children surviving a cancer diagnosis today, this issue is increasingly important for childhood cancer survivors. This article has reviewed existing literature examining peripheral neuropathy in childhood cancer survivors with particular interest paid to measurement tools available and needs for future research. It is important for nurses to choose appropriate measures for clinical care and research methods in order to have an impact on patients experiencing this condition.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Pharmacokinetics in Pediatric Patients: Drug Excretion
Treatment Resistant Cancers
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Pharmacokinetics in Pediatric Patients: Drug Distribution
